Product Images Radicava

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 28 images provide visual information about the product associated with Radicava NDC 70510-2171 by Mitsubishi Tanabe Pharma America, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chemical structure

figure 01

ifu figure a

ifu figure b

ifu figure c

ifu figure d

ifu figure e

ifu figure f

ifu figure g

ifu figure h

ifu figure i

ifu figure j

ifu figure k

ifu figure l

ifu figure n

ifu figure o

ifu figure p

ifu figure q

ifui figure m

radicava carton sawaii

radicava carton terumo

radicava ors label maintenance

Radicava ORS (edaravone) Oral Suspension is a medication manufactured for Mitsubishi Tanabe Pharma America, Inc. It is used for oral administration and comes in a 50 mL bottle. The suspension contains 105 mg/5 ml of edaravone and should be shaken vigorously before use. The unused portion should be discarded 15 days after first opening. It should be stored between 2-8°C (36-46°F) and protected from light. Patients should store it upright at room temperature between 20°C-25°C (88°F-77°F) and should also protect it from light. The suspension should be mixed well before each use, and dosage should be according to Prescription Information.*

radicava ors label starter

This is a description of a medication with the name Radicava ORS. This medication comes in a 35mL bottle and is used for oral administration. The medication should be shaken vigorously before each use. The unused portion should be discarded 15 days after the first opening. This medication contains 105 mg of edaravone per 5 mL, and is opaque and homogeneous. It is manufactured by Mitsubishi Tanabe Pharma America. This medication should be stored in a pharmacy between 2°C to 8°C and must not freeze while upright. Before each use, the bottle should be shaken for at least 30 seconds to confirm that the white liquid is completely mixed. The recommended dosage of this medication is indicated in the prescribing information.*

radicava ors maintenance carton

radicava ors starter carton outer

This appears to be a jumbled mix of text and characters without any coherent meaning or context, hence it is not possible to generate a useful description.*

radicava ors starter inner carton

radicava soft bag sawai

This appears to be a label for the medication Radicava (edaravone) injection, with a concentration of 30mg/100mL. The label provides warnings and precautions for usage and storage of the medication.*

radicava soft bag terumo

Radicava (edaravone) Injection is an intravenous infusion medication containing 30 mg edaravone per 100 mL bag. The inactive ingredients include L-cysteine hydrochloride hydrate, sodium bisulfite, sodium chloride for isotonicity, and phosphoric acid and sodium hydroxide to adjust pH. The medication should only be administered via IV infusion for 30 minutes. The package should be used within 24 hours of opening, and unused IV solution should be discarded. Radicava should not be mixed with other drugs, and the bag should be discarded if leaks are found. The medication is manufactured by Terumo Corporation in Japan and marketed by Mitsubishi Tanabe Pharma America, Inc. in Jersey City, NJ. Storage is recommended at up to 25°C (77°F).*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.